Found 4 matching trials
Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease
PHASE2To investigate the severity of secondary Raynaud's disease-related attacks ...
Location
University des Saarlandes
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
PHASE2The goal of this clinical trial is to learn if the drug RT-001 works to red...
Location
Retension Clinical Site
Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension
PHASE2The purpose is to determine the effect of SLx-2101 dosed at 5mg or 10mg for...
Location
Parexel, Institute for Clinical Pharmacology
Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension
PHASE2The purpose is to determine the effective dosage and to study the effects o...
Location
Addenbrooke's Hospital